DiaMonTech is developing a medical device for non-invasive measurement of blood sugar values.
DiaMonTech has raised €8.0M across 3 funding rounds from 3 investors, most recently a round in Sep 2025. Based in Berlin, Germany; founded 2015; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2025-09-17 | Other | €8.0M | Companisto,Samsung Next | View deal → |
| 2023-12-11 | Other | — | Moll Family | View deal → |
| 2019-10-01 | Series A | €0 | — | View deal → |
